Literature DB >> 8430110

Differential patterns of DNA binding by myc and max proteins.

E V Prochownik1, M E VanAntwerp.   

Abstract

c-myc, N-myc, and L-myc genes are subject to highly variable degrees of tissue-specific regulation. Their aberrant expression has also been implicated in the pathogenesis of a variety of malignant tumors. The recently identified max protein dimerizes with c-myc to promote its sequence-specific DNA binding. max exists in two forms (long and short) that differ by virtue of a 9-amino acid insertion/deletion at the N terminus. We tested recombinant myc and max proteins for binding to six oligonucleotides containing related c-myc sites. Each myc protein, alone and in association with max proteins, manifested a unique pattern of DNA binding. Phosphorylation of both max proteins was observed when they were incubated in a rabbit reticulocyte lysate. This strongly affected DNA binding by max(long) but not by max(short). Our results point to the existence of specific DNA binding preferences for each of the myc proteins. The 9-amino acid segment that distinguishes max(long) from max(short) appears to serve a regulatory function that provides additional control over DNA sequence recognition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430110      PMCID: PMC45790          DOI: 10.1073/pnas.90.3.960

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A point mutation in the MyoD basic domain imparts c-Myc-like properties.

Authors:  M E Van Antwerp; D G Chen; C Chang; E V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Cyclic nucleotide-independent protein kinases from rabbit reticulocytes. Purification of casein kinases.

Authors:  G M Hathaway; J A Traugh
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

3.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

4.  Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region.

Authors:  M Sawadogo; R G Roeder
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

5.  Tissue and cell type-specific expression of two human c-onc genes.

Authors:  R Müller; J M Tremblay; E D Adamson; I M Verma
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma.

Authors:  J Battey; C Moulding; R Taub; W Murphy; T Stewart; H Potter; G Lenoir; P Leder
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

8.  Human N-myc is closely related in organization and nucleotide sequence to c-myc.

Authors:  N E Kohl; E Legouy; R A DePinho; P D Nisen; R K Smith; C E Gee; F W Alt
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

9.  Differential expression of myc family genes during murine development.

Authors:  K A Zimmerman; G D Yancopoulos; R G Collum; R K Smith; N E Kohl; K A Denis; M M Nau; O N Witte; D Toran-Allerand; C E Gee
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

10.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

View more
  14 in total

1.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Family matters: How MYC family oncogenes impact small cell lung cancer.

Authors:  Johannes Brägelmann; Stefanie Böhm; Matthew R Guthrie; Gurkan Mollaoglu; Trudy G Oliver; Martin L Sos
Journal:  Cell Cycle       Date:  2017-07-24       Impact factor: 4.534

3.  Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

Authors:  Kwan-Young Jung; Huabo Wang; Peter Teriete; Jeremy L Yap; Lijia Chen; Maryanna E Lanning; Angela Hu; Lester J Lambert; Toril Holien; Anders Sundan; Nicholas D P Cosford; Edward V Prochownik; Steven Fletcher
Journal:  J Med Chem       Date:  2015-03-30       Impact factor: 7.446

Review 4.  Gene profiling of high risk neuroblastoma.

Authors:  Sanjeev A Vasudevan; Jed G Nuchtern; Jason M Shohet
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors.

Authors:  Huabo Wang; Anand Ramakrishnan; Steven Fletcher; Edward V Prochownik
Journal:  J Biol Methods       Date:  2015

6.  Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.

Authors:  Derek M Murphy; Patrick G Buckley; Kenneth Bryan; Sudipto Das; Leah Alcock; Niamh H Foley; Suzanne Prenter; Isabella Bray; Karen M Watters; Desmond Higgins; Raymond L Stallings
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

7.  Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs.

Authors:  Laura C Cobbold; Keith A Spriggs; Stephen J Haines; Helen C Dobbyn; Christopher Hayes; Cornelia H de Moor; Kathryn S Lilley; Martin Bushell; Anne E Willis
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

8.  Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.

Authors:  G Anand; D N Shapiro; P S Dickman; E V Prochownik
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

9.  MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.

Authors:  Christopher J Walker; Craig M Rush; Paola Dama; Matthew J O'Hern; Casey M Cosgrove; Jessica L Gillespie; Roman A Zingarelli; Blair Smith; Maggie E Stein; David G Mutch; Reena Shakya; Chia-Wen Chang; Karuppaiyah Selvendiran; Jonathan W Song; David E Cohn; Paul J Goodfellow
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

10.  Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.

Authors:  Huabo Wang; James M Dolezal; Sucheta Kulkarni; Jie Lu; Jordan Mandel; Laura E Jackson; Frances Alencastro; Andrew W Duncan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.